Profile of genetic disorders prevalent in northeast region of Cairo, Egypt  by Shawky, Rabah M. et al.
The Egyptian Journal of Medical Human Genetics (2012) 13, 45–62Ain Shams University
The Egyptian Journal of Medical Human Genetics
www.ejmhg.eg.net
www.sciencedirect.comORIGINAL ARTICLEProﬁle of genetic disorders prevalent in northeast region
of Cairo, EgyptRabah M. Shawky a,*, Nermine S. Elsayed b, Doaa S. Ibrahim b,
Neveen S. Seifeldin ca Pediatrics Department, Ain-Shams University, Egypt
b Medical Genetics Center, Ain-Shams University, Egypt
c Dermatology Department, Ain-Shams University, EgyptReceived 29 May 2011; accepted 20 October 2011
Available online 4 February 2012*
Sh
22
E-
11
El
Pe
doKEYWORDS
Genetic disorders;
Congenital malformations;
Inbreeding proﬁle;
Northeast region;
Cairo;
EgyptCorresponding author. Add
ams University, Cairo, Egy
585577.
mail address: shawkyrabah@
10-8630  2012 Ain Shams
sevier B.V. All rights reserve
er review under responsibilit
i:10.1016/j.ejmhg.2011.10.00
Production and hress: Me
pt. Tel.:
yahoo.co
Universit
d.
y of Ain
2
osting by EAbstract As clinical geneticists, we recently reviewed our 43 years experience in an attempt to rep-
resent the frequency of genetic disorders in the Division of Genetics at Pediatric Hospital, Faculty
of Medicine, Ain-Shams University, Cairo, Egypt, during the period from 1966 to 2009.
All patients (from birth up to 18 years) suspected of having a genetic disorder were referred to the
Genetics Clinic in the same hospital. 28,689 Patients were proved to have genetic disorders after full
investigations among 660,280 children attending the Pediatrics Hospital which constituted 4.35% or
43.5/1000. Neurologic disorders were the most common (31.38%) followed by hematologic
disorders (18.48%), chromosomal abnormalities (11.51%), fetal, neonatal and infant deaths
(6.56%), special senses (5.82%), inborn errors of metabolism (4.24%), endocrine disorders
(3.87%), skeletal disorders (3.17%), genito-gonadal anomalies (3.10%), neuromuscular disorders
(2.86%), syndromes (2.08%), genodermatoses (1.92%), cardiac disorders (1.47%), gastrointestinal
tract anomalies (1.37%), renal anomalies (0.26%), connective tissue disorders (0.26%), respiratory
defects (0.22%), vascular anomalies (0.21%), and immunologic disorders were the least common
(0.19%).dical Genetics Center, Ain-
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46 R.M. Shawky et al.Our study showed a high prevalence of genetic diseases among Egyptians which are nearly the
same in the other studies in Egypt and are rapidly becoming a major public health concern. Estab-
lishment of national or hospital based registers for genetic disorders is very important to know the
magnitude of the problem so that the national program for the prevention of genetic disorders can
be implemented.
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Hereditary diseases and congenital malformations have been
reported to affect 2–5% of all livebirths [1]. The British
Columbia Health Surveillance Registry shows that before the
age of 25, at least 53 out of 1000 liveborn individuals can be
expected to have a disease with an important genetic compo-
nent. This comprises 3.6 single gene disorders per 1000, 1.8
chromosomal disorders per 1000, 46.4 multifactorial or part-
genetic disorders per 1000 and 1.2 genetic type of uncertain
disorders per 1000. In this analysis, congenital anomalies were
included only if a multifactorial or part-genetic etiology had
been established, but if all congenital abnormalities were in-
cluded the cumulative ﬁgure rose to more than 79 per 1000
livebirths [2]. Available evidence suggests that congenital and
genetic disorders are responsible for a major proportion of in-
fant mortality, morbidity, and handicap in Arab countries [3].
Egyptwas classiﬁed as one of themore developedArab coun-
tries according to categorization of the Committee of Develop-
ment Policy (CDP) [4]. Egypt, one of themain civilisations of the
ancient world, has a history that goes back more than
5000 years. It enjoys a distinguished geographical location at
the juncture of the ancient world continents of Africa, Asia
and Europe. It has always been a place of inter-civilization
and reactivation between the East andWest as well as the North
and South. It was also the crossing road of the heavenly religious
of the World. It is about 1 million (m) km2 and is located in the
north-eastern corner of Africa and Southwestern Asia [5].
Egypt is divided into three main geographical regions: the
Nile Vally, the Eastern desert and the Western desert. The Nile
Vally represents 4% from the area of Egypt and is divided into
Upper Egypt region, Lower Egypt region, Suez Canal region
and Northern coast lakes region. It is also divided into 27
governorates.
Cairo, the most populous Arab country, is the glorious cap-
ital of Egypt. Cairo’s population rose to more than 18 millions
(the highest population density in Egypt). Egyptians are
mainly descended from ancient Egyptian Society (94%). Eth-
nic minorities in Egypt include, Nubians, Berbers, Bedouin
Arabs, Beja and Dome (4%) and others (2%) [5].
1.1. Demographic features of Egypt
Egyptian population according to census 2006 hit 76.5 million,
around 3.9 million are living abroad. One Egyptian baby is
born every 23 s, birth rate 22.94 births/1000.
In Egypt, birth rates among women over 35 years have been
almost twice (65/1000) as often as those occurring among wo-
men of the same age in USA (33.7/1000) [6]. Old maternal age
is associated with aberrant genetic recombination or similar
genetic mechanisms together with one or more environmental
factors [7]. Moreover, risks to the fetus could have beenmodulated by the effects of aging on the mother’s general or
reproductive health [8]. Other investigators have suggested that
physiologic changes associated with aging and or environmen-
tal factors may increase birth defects [9,10]. In Egypt advanced
maternal age has signiﬁcant role in causation of repeated abor-
tions [11].
1.2. Consanguinity among Egyptians
While ancient Egyptians of the reigning dynasty (1580–1350
BC) favored marriages of brother and sisters among the royal
family, current laws of the Egyptian society emphasize the va-
lue of outbreeding and prohibit marriages between relatives
closer than ﬁrst cousins.
Consanguineous marriage is still high in Egypt (35.3%)
especially among ﬁrst cousins (86%). However, the frequency
varies by region. It is higher in Sohag (42.2%) and Cairo
(36.1%) than in Assuit (21.7%). Also it was higher in rural
areas (59.9%) than in semiurban and urban areas (23.5%)
and (17.7%), respectively [12]. This increase in consanguinity
rate is due to the fact that many families prefer marriage
among ﬁrst cousins to preserve family structure, links and pro-
vide social, economics and cultural beneﬁts. Many Egyptians
believe that there may be more compatibility and less tendency
to divorce between husband and wife from a family. This fa-
vored the appearance of complex phenotypes of genetic disor-
ders which result in difﬁculties in phenotype classiﬁcation.
1.3. Effect of inbreeding on the genetic morbidity
This high consanguinity rate is reﬂected on higher risk of in-
fant and child mortality in Egypt. There was 30% and 19%
higher risk of infant mortality among close and remote con-
sanguineous couples, respectively. Similarly the risk of child
mortality is found higher among close consanguineous couples
by more than 50% and among remote consanguineous couples
by 27% as compared to non-consanguineous marriage [12,13].
Consanguinity also increases birth prevalence of severe
recessive disorders, appearance of new autosomal recessive
syndromes, multiple genetic disorders in the same individual
or same family and homozygosity for autosomal dominant dis-
orders. Consanguinity also increases the risk of birth of a child
with a malformation [14].
Several genetic disorders have been reported to be frequent
among Egyptians [4,15]. This observation could be the result
of an ascertainment bias resulting from a possible higher
awareness of the hereditary disorders in Egypt.
2. Aim of the study
As clinical geneticists, we recently reviewed our 43 years expe-
rience in an attempt to represent the frequency of genetic
Genetic disorders in Egypt 47disorders in the Division of Genetics at Pediatric Hospital,
Faculty of Medicine, Ain-Shams University.
This faculty was constructed in 1947, to be the third Med-
ical school in Egypt. Ain-Shams University Hospitals contain
3200 beds. The educational hospitals and specialized clinics
serve 1 million patient/year at the outpatient and inpatient
departments [16].
The Pediatric Hospital is located in the northeast section
of Cairo. It has a good reputation and high standard of
health care so nearly all patients in this area attend this hos-
pital. Also patients come nearly from all governorates to re-
ceive good health care in this hospital (Fig. 1) [17]. The
Genetics Clinic present in this hospital is constructed in
1964, it is the ﬁrst Genetics Clinic not only in Egypt but also
in all Arabic countries. It offers counseling to patients with
partial and total genetic diseases. Counseling is available
for patients of both sexes and all ages, from public and pri-
vate health centers and several medical specialties. So the fre-
quency of genetic disorders in this hospital will represent to a
great extent the frequency in the general population. This will
greatly help in determining the size of the problem in Egypt
and increase health authorities, physician and public aware-
ness of genetic disorders.Figure 1 Map o3. Subjects and methods
The sample size studied was 660,280 patients attending the
Pediatric clinic, Ain-Shams University hospital (from birth
up to 18 years), during the period of the study from 1966 to
2009. All children suspected of having a genetic disorder were
referred to the Genetics Clinic in the same hospital. Charts of
children with proved genetic disorders were extracted (28,689).
We studied the frequency of genetic disorders in the genetic
clinic as well as in the Pediatric Hospital.
Patients selection was based on history (personal, medical,
family and developmental), pedigree analysis clinical examina-
tion of all body systems and investigations related to various
diseases, e.g. karyotype, FISH, molecular study, metabolic
screening, enzyme assay, psychological evaluation, IQ scoring,
X-rays, ultrasonography, echocardiography, ECG, EMG,
nerve conduction velocity, histopathology, brain imaging, etc.
In addition to depending on retrospective surveys of medi-
cal records in Genetics Clinic to ascertain genetic cases, we de-
pended also on various studies published on national and
international journals on patients attending our hospital.
We used the outpatients index ﬁles to identify diagnosed
cases of albinism referred from the dermatologic andf Egypt [17].
48 R.M. Shawky et al.ophthalmologic departments with different genodermatoses
over 43 year period. We used speciﬁcally designed data collec-
tion protocol forms to extract epidemiological and clinical data
from the patients medical records. These were entered into a
computer database and analyzed using standard statistical soft-
ware (Standard Package for Social Sciences version VII).
4. Results and discussion
28,689 Patients were proved to have genetic disorders after full
investigations among 660,280 children attending the Pediatrics
Hospital which constituted 4.35% or 43.5/1000. NeurologicTable 1 Demonstrate frequency of genetic disorders among 28,6
attending the Pediatrics Hospital. It is a representative of prevalence
Categories No.
Neurologic disorders 9005
Hematologic disorders 5304
Chromosomal abnormalities 3376
Fetal, neonatal and infant deaths 1924
Special senses 1708
Inborn errors of metabolism (IEM) 1244
Endocrine disorders 1136
Skeletal disorders (osseous and chondral) 930
Genito-gonadal anomalies 908
Neuromuscular disorders 823
Syndromes 610
Genodermatosis 553
Cardiac disorders 432
Gastrointestinal tract anomalies 403
Renal anomalies 75
Connective tissue disorders 75
Respiratory defects 64
Vascular anomalies 62
Immunologic disorders 57
Total 28,689
31.38
18.48
11.51
6.56 5.82
4.24 3.87 3.17 3.1
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Figure 2 Frequency of genetic disorders among 28,689 patients a
Pediatrics Hospital.disorders were the most common (31.38%) followed by hema-
tologic disorders (18.48%), chromosomal abnormalities
(11.51%), fetal, neonatal and infant deaths (6.56%), special
senses (5.82%), inborn errors of metabolism (4.24%), endo-
crine disorders (3.87%), skeletal disorders (3.17%), genito-go-
nadal anomalies (3.10%), neuromuscular disorders (2.86%),
syndromes (2.08%), genodermatoses (1.92%), cardiac disor-
ders (1.47%), gastrointestinal tract anomalies (1.37%), renal
anomalies (0.26%), connective tissue disorders (0.26%),
respiratory defects (0.22%), vascular anomalies (0.21%), and
immunologic disorders were the least common (0.19%).
(Table 1 and Fig. 2).89 patients attending the Genetics Clinic and 660,280 patients
of genetic diseases in Egypt to a great extent.
% In Genetics Clinic % In hospital
31.38 1.36
18.48 0.80
11.51 0.51
6.56 0.29
5.82 0.26
4.24 0.19
3.87 0.17
3.17 0.14
3.10 0.14
2.86 0.12
2.08 0.09
1.92 0.08
1.47 0.07
1.37 0.06
0.26 0.01
0.26 0.01
0.22 0.01
0.21 0.01
0.19 0.01
100.00 4.44
2.86 2.08 1.92 1.47 1.37 0.26 0.26 0.22 0.21 0.19
ttending the Genetics Clinic and 660,280 patients attending the
Genetic disorders in Egypt 49In another study done in Egypt, but in another locality,
(Giza, upper Egypt), the genetic counseling group represented
the highest percentage (17%), followed by neurologic disorders
(9.5%), chromosomal disorders (9.3%), mental retardation
and behavioral disorders (8.1%), neuromuscular disorders
(5.7%), metabolic disorders (5.3%), endocrine disorders and
skeletal disorders (4.9%) each. Dermatological and renal dis-
orders represented the least common referral disorders (1.1%
and 0.5%), respectively. In 27.9% of this study the etiology
was unknown [15].
A considerable variation in the frequency of various genet-
ic/malformation disorders had been previously reported in dif-
ferent Arab countries [3,18,19]. This variability could be due to
different classiﬁcations used in different studies.
4.1. Neurologic disorders
They constituted 31.38% of patients attending the Genetics
Clinics and 1.36% in the Pediatric Hospital. Mental deﬁciency
was the commonest disorder and neuroectodermal disorders
were the least common (Table 2).
Mental retardation: Mental retardation constituted 46.48%
of neurologic disorders among our patients. As regards the eti-
ology of mental retardation, prenatal causes was detected in
32.6% of cases, perinatal in 18.2%, postnatal in 3.7%, meta-
bolic causes in 22.7% and 22.8% were unclassiﬁed. Genetic
causes of mental retardation were more common (80.4%) than
non-genetic causes (19.6%). Among the genetic causes, chro-
mosomal aberrations (33%), followed by inborn errors of
metabolism (22.6%) were among the most common causes
[20]. A prevalence of Fragile X syndrome among Egyptian
males was reported as 0.9/1000 or 6.4% among mentally sub-
normal males [21].
Convulsive disorders: In our study, inherited epilepsy was
detected in 22.22% of our patients with neurologic disorders.
A study to evaluate the state of zinc (Zn), copper (Cu), magne-
sium (Mg) and manganese (Mn) in different convulsive disor-
ders affecting children and to evaluate the effect of
anticonvulsant therapy on these trace elements was conducted
by Shawky et al. [22]. Results revealed that serum Cu was high-
er in epileptics whether treated or not than controls (p< 0.05).Table 2 Genetic varieties of neurologic disorders prevalent
among Egyptians.
Category Genetics Clinics
No. %
Neurological disorders 9005 100.00
Mental deﬁciency 4186 46.48
Inherited epilepsy 1977 22.22
Craniocerebral anomalies 1366 15.35
Microcephaly 581 6.53
Hydrocephalus 210 2.36
Craniosynostosis and other cranial anomalies 116 1.30
Unidentiﬁable 459 5.16
Neural tube defects 910 10.23
Neurodegenerative disorders 468 5.26
Neurocutaneous disorders 98 1.10
Neuroﬁbromatosis 55 0.62
Sturge weber syndrome 24 0.27
Tuberous sclerosis 19 0.21As regards serum Zn, Mg and Mn, there was no signiﬁcant dif-
ference between epileptics compiled as one group and controls
(p> 0.05).
Type, etiology and frequency of seizures had no effect on
serum level of the studied trace elements. Interval from last sei-
zure to sampling had effect only on serumMn which was lower
when sampling was done on the same day and one or two days
after the last seizure (p< 0.05). There was no correlation be-
tween duration of therapy or plasma level of phenobarbital
and phenytoin on one hand and serum level of Zn, Cu, Mg
or Mn on the other hand (p> 0.05).
Shawky et al. [23] estimated the serum haptoglobin level
(using radial immune diffusion) in 32 epileptic children (10
with familial and 22 with non-familial epilepsy) and compared
to its level in 14 healthy age and sex matched children and 10
relatives of familial epilepsy. Serum haptoglobin was found to
be signiﬁcantly lower in familial epileptics and the group of rel-
atives. There was also an insigniﬁcant decrease of haptoglobin
in relatives than in healthy children, while non-familial epilep-
tics had higher values than healthy children, familial epileptics
and their relatives. Lower values of haptoglobin in familial epi-
leptics which might be inherited would suggest possible rela-
tion to the etiology of epilepsy; while higher values in non-
familial epileptics could reﬂect an acute phase reactant which
might act in the pathogenesis of epilepsy.
Craniocerebral anomalies: Craniocerebral anomalies consti-
tuted 15.35% of neurologic disorders and included:
Microcephaly, constituted 6.53% of neurologic disorders
among our patients. Isolated microcephaly was detected in
3.4%. Forty-eight percent of cases were part of a syndrome.
Environmental causes were detected in 17.2% and 6.8% were
manifested in cases of inborn errors of metabolism (IEM) [24].
Hydrocephalus, constituted 2.36% of the neurologic disor-
der group. Forty-four Egyptian hydrocephalic infants and
children were included in a study to detect the genetic aspects
and possible modes of inheritance in different types of hydro-
cephalus. The study revealed that 37 cases had congenital
hydrocephalus, (13 with congenital aqueductal stenosis
(CAS), eight with Arnold Chiari malformation, ﬁve with con-
genital toxoplasmosis, one with Dandy walker malformation,
one with Aneurysm of Galen, one with arachnoid cyst and
eight with undeﬁned causes). Seven had acquired hydrocepha-
lus (four postmeningitic and three posttraumatic). Male pre-
dominance (1.6:1) was noticed in congenital hydrocephalus.
In CAS, increased male incidence (8/13) and positive family
history (4/8) with affected males on the maternal side might
suggest X-linked recessive trait. On the other hand, consan-
guineous mating was detected in 46% of cases with congenital
hydrocephalus that may give some impression of the role of
autosomal recessive mode of inheritance. First born infants
were more frequently affected (38%) than in subsequent preg-
nancies (19%). History of mental retardation in sibs of three
cases with congenital hydrocephalus was suggestive of limited
expression of the gene. Maternal toxoplasmosis was the only
environmental antenatal factor involved in the development
of hydrocephalus while the inﬂuences of maternal age, nutri-
tion, and medications were not impressive [25].
Craniosynostosis, constituted 1.30% of neurologic disorders
group. Craniosynostosis is a heterogeneous condition charac-
terized by premature closure of sutures. A study was con-
ducted on 50 patients in our clinic with craniosynostosis to
detect the etiology. Patients were classiﬁed into primary and
Table 3 Genetic varieties of hematologic disorders prevalent
among Egyptians (Khalifa AS. Personal communication) [36].
Category Hematologic clinic
No. %
Hematologic disorders 5304 100.00
b-thalassemia (Major, intermediate) 1124 21.19
b-thalassemia Trait 127 2.39
a-thalassemia 13 0.25
Sickle cell anemia 195 3.68
G6PD 1320 24.89
ITP 953 17.97
Hemophilia A 332 6.26
Hemophila B 29 0.55
Aplastic anemia 201 3.79
AIA 120 2.26
FA 10 0.19
Other HA 216 4.07
AFI 97 1.83
Thrombasthenia 95 1.79
Cong. Spherocytosis 91 1.72
vonWillibrand disease 68 1.28
Pure red cell aplasia 38 0.72
Megalobalstic anemia 38 0.72
Gaucher 35 0.66
Marble bone disease 13 0.25
Others 189 3.56
50 R.M. Shawky et al.secondary craniosynostosis according to history, clinical exam-
ination and investigations. Primary craniosynostosis included
30 patients and was further subdivided into three subgroups
according to the shape of the skull and sutures involved; sub-
group I ‘‘Oxycephaly’’ included 56.7% of patients: 76.44% of
them with primary isolated oxycephaly, 5.9% of cases were
associated with Arnold Chiari malformation, 11.76% with
Crouzon syndrome and 5.9% with Apert syndrome; subgroup
II ‘‘scaphocephaly’’ included 33.3% with primary isolated
scaphocephaly; subgroup III ‘‘heterogeneous’’ included 10%
of cases out of whom 33.3% had plagiocephaly, 33.3% had
brachycephaly and 33% had oxy-scaphocephaly. Forty per-
cent of the primary craniosynostosis cases had mental retarda-
tion and 86.7% were sporadic. Secondary craniosynostosis
included 20 patients (40%), 50% had cerebral palsy, 20%
had mucopolysaccharidosis, 15% with postshunt craniosynos-
tosis, 5% with osteopetrosis, (5%) with neglected vitamin D
deﬁciency rickets and 5% had encephalocele with multiple
congenital anomalies [26].
Neural tube defects: Neural tube defects constituted 10.23%
of neurologic disorders among our patients. Hafez and
Hashem [27] reported an incidence of NTD among Egyptian
children of 3.7–6.96% which is considered high. Thirty-seven
percent had severe defects and 16% had other associated
abnormalities as a part of a syndrome. Abdelaleem et al. [28]
reported that C677T polymorphism of the 5,10-methylene tet-
rahydrofolate reductase (MTHFR) gene is a risk factor for
neural tube defects among Egyptians.
Neurodegenerative disorders: Neurodegenerative disorders
constituted 5.26% of neurologic disorders among our patients.
A study was conducted in order to detect the etiology among a
sample of our children suffering from neurodegenerative dis-
eases. Among them 3.33% had Gaucher disease, 3.33% had
aryl sulfatase A pseudodeﬁciency, 3.33% had most probably
Pelizaeus–Merzbacher disease, 6.66% had infantile metachro-
matic leukodystrophy while another 6.66% had congenital
muscular dystrophy. No cases with Krabb’s disease were de-
tected in this study [29].
Neurocutaneous disorders: Neurocutaneous disorders con-
stituted 1.10% of our patients with neurologic disorders. Neu-
roﬁbromatosis was the commonest, followed by Sturge–Weber
syndrome and tuberous sclerosis while in another study the
most common type was tuberous sclerosis (34.8%), followed
by neuroﬁbromatosis type 1 (26.1%), Sturge–Weber syndrome
(21.7%), Klippel–Trenauny–Weber syndrome (8.7%), inconti-
nentia pigmenti (4.3%) and multiple lentiginous syndrome
(4.3%). The presenting manifestations of neurocutaneous syn-
dromes were diverse and included developmental delay and/or
learning disabilities in 43.5%, recurrent ﬁts in 39.1%, skin le-
sions in 30.4%, growth retardation in 26.1%, skeletal abnor-
malities in 13% and hearing, visual and speech defects in
4.3% [30].
4.2. Hematologic disorders
During the period of the study, 5304 new patients with various
hematologic disorders attended the Pediatric Hematology/
Oncology Clinic, Ain-Shams University.
Hematologic disorders constituted 18.48% of genetic disor-
ders and 0.8% of patients attending the Pediatric Hospital. Ta-
ble 3 represents the distribution of different hematologicdisorders. G6PD deﬁciency was the most common hemato-
logic disorder detected in our clinic (24.89%) followed by
b-Thalassemia (21.19%), idiopathic thrombocytopenic
purpura (ITP) (17.97%), and hemophilia A (6.26%).
Thalassemias
b-Thalassemia
b-Thalassemia is a congenital hemolytic anemia characterized
by partial or complete deﬁciency in the production of beta glo-
bin chains [31]. In Egypt, b-thalassemia is the commonest
cause of chronic hemolytic anemia and it represents a major
genetic disease and a public health problem [32]. In Egypt
more than one thousand affected cases are expected to be born
every year in Egypt [33]. The estimated carrier rate is 9–10%
[34], with a gene frequency of 0.03 [35]. Although the available
treatment has increased the life expectancy of patients, it is still
unsatisfactory and represents a signiﬁcant drain on the coun-
try’s resources. In a study on 5304 patients attending the hema-
tology clinic (Table 3). b-Thalassemia major patients
represented (21.19%) and b-thalassemia minor (2.39%) [36].
The relative frequency of different b-thalassemia mutations
and their association with beta-globin haplotypes was studied
by Novelletto et al. [35], in the ﬁrst Egyptian study in patients
from the Nile delta region, Egypt. They found eight mutations
accounting for 77% of b-thalassemia mutations, the common-
est three being IVS-1 nt 110, IVS-1 nt 6 and IVS-1 nt 1. This is
consistent with all next studies on Egyptian patients where
these ﬁrst three mutations were the most frequent alleles in
Egyptian patients with a different frequencies; 55.88%
[37,38], 62.5% [39], 78% [40], and 73% [32].
Less frequent mutations were 15 CD 22 A–C and 1 FS CD
28 C mutations in exon 1 [41], codon 24 (G; +CAC) [34]
Table 4 Varieties of chromosomal abnormalities prevalent
among Egyptians.
Category Genetics Clinics
No. %
Chromosomal abnormalities 3376 100.00
Autosomal abnormalities 2744 81.25
Down syndrome 2523 74.71
With maternal age >30 years 1432 42.40
With maternal age <30 years 1091 32.30
Other trisomies 78 2.30
Chromosome deletions 143 4.23
Sex chromosome abnormalities 632 18.72
Turner syndrome 254 7.52
Klinefelter syndrome 130 3.85
Fragile X syndrome 248 7.34
Genetic disorders in Egypt 51and promoter region 87 (Cﬁ G), codon 27 (Gﬁ T), IVS-II-
848 (Cﬁ A) mutation, Codon 37 (Gﬁ ), frameshift codon 5
(CT) mutation, and codon 15 (TGGﬁ TGA) mutation [42].
In 1993, Craig et al. [43] described an Egyptian family with
db-thalassemia caused by 13.4-kb deletion that removes the 30
region of the d gene, the entire b gene, and its 30 ﬂanking se-
quences extending into the 6.4-kbL1 repeat element. They
proved that this deletion is identical to those of the Sicilian
(db) thalassemia.
Since 1990 the spectrum of b-thalassemia mutations were
identiﬁed and prenatal diagnosis started in Egypt by applying
amniocentesis and ARMS-PCR [44]. In 2003, prenatal diagno-
sis was done on fetal DNA in maternal circulation using dena-
turing high performance liquid chromatography (DHPLC)
after ARMS-PCR ampliﬁcation of all the DNA samples [45].
a-Thalassemia
In this study it represented 0.25% of patients in hematology
clinic. Novelletto et al. [46] demonstrated a frequency of dele-
tion of a-thalassemia among Egyptians as 0.08.
Sickle cell anemia: It is the commonest single gene disorder
worldwide [47]. About 1.92% of the world’s population carry
sickle hemoglobin [48]. Hemoglobin S is found in the Mediter-
ranean area and its presence there can be attributed to gene
ﬂow from Africa [49,50]. In parts of Africa, up to a third of
the people carry a gene for hemoglobin S. About 120,000 ba-
bies with sickle cell disease are born yearly, but less than 2%
survive to the age of ﬁve [51].
In our study it represented 3.68 of patients attending the
hematology clinic. El Beshlawy et al. [52] found 1.6% preva-
lence of sickle cell disease, while Khalifa et al. [36] reported
incidences 6.7% and 4.94%.
In 1999, Marin et al. [53] conducted a molecular investiga-
tion for the presence of sicklemia in six predynastic Egyptian
mummies (about 3200 BC) from the Anthropological and Eth-
nographic Museum of Turin. DNA was extracted from dental
samples with a silica-gel method speciﬁc for ancient DNA.
Ampliﬁcation refractory mutation system (ARMS) was then
applied. In samples of three individuals, there was a band at
the level of the HbS mutated fragment, indicating that they
were affected by sicklemia.
In 1994, El Beshlawy et al. [39] found that the Benin haplo-
type is the predominant haplotype in the sickle cell disease in
Egypt. The same results were also reported by Shawky et al.
[54] with incidence of Benin haplotype (52%), followed by
atypical haplotype (36%), and no correlation was observed be-
tween clinical severity and haplotype.
G6PD deﬁciency: Glucose-6-phosphate dehydrogenase
(G6PD) deﬁciency is the most common human enzyme defect,
being present in more than 400 million people worldwide [55].
The ﬁrst report on the incidence of G6PD deﬁciency among
Egyptians appeared in early 1966, following an earlier WHO
report which listed as ‘‘non-existent’’ [56]. In ﬁrst report, Ra-
geb et al. [57] reported incidence of 26.4%. Different inci-
dences were reported later; 4.9% [58], 7.5–14.5% in Lower
Egypt compared to 3% in Upper Egypt [59], and 5.9% [60].
Lippi [61] considered the hypothesis that the ancient Egyptians
had noticed the potential deadly effect of broad beans’ use. In
this study, it represented an incidence of 24.89%.
A total of 3,501 male subjects from six Arab countries
living in Kuwait were investigated for quantitative andphenotypic distribution of red cell glucose-6-phosphate dehy-
drogenase (G6PD). The ethnic origins of those investigated
were Kuwait, Egypt, Iran, Syria, Lebanon and Jordan. The
distribution of G6PD deﬁciency among the different ethnic
groups varied widely, ranging from 1.00% for Egyptians to
11.55% for Iranians [62].
Settin et al. [63] reported that the minimum frequency of
G6PD deﬁciency among jaundiced Egyptian neonates is
11.4% which is higher than population prevalence in Egypt
(7–9.9%), and relatively higher than some countries like Iran
(7.5%) but lower than Greece, Turkey and Jamaica.
Hemophilia: Hemophilia is an X-linked hereditary bleeding
disorder caused by a deﬁcient or defective coagulation factor
VIII (hemophilia A) or factor IX (hemophilia B) [64]. Khalifa
et al. [65] reported an incidence of 7.01% of hemophilia A and
0.47% of hemophilia B, and 0.63% of von Willebrand’s dis-
ease of patients with bleeding disorder and in this study it rep-
resented 6.26% (hemophilia A) and 0.55% (hemophilia B) of
patients attending the hematology clinic. In 2000, Khalifa
et al. [65] also reported the possibility to offer diagnosis in
68.4% of the studied families with the combined use of both
intron 13 and intron 22 repeats. Intron 13 and 22 of factor VIII
gene are multi allelic- dinucleotide tandem repeats used for
indirect gene tracking [66,67].
4.3. Chromosomal disorders and congential malformations
Chromosomal disorders represented a signiﬁcant class of ge-
netic disorders in Egypt and constituted 11.77% and 0.51%
in genetics and general pediatrics clinics, respectively (Table 4).
It is the cause of congenital abnormalities in 5/1000 in in-
fants and children, over 6% of early spontaneous abortions
and 6–7% of still births and neonatal deaths. One percent of
chromosomal disorders is transmitted from a carrier of a bal-
anced chromosomal rearrangements and the rest are due to de-
novo abnormality [68].
Autosomal chromosomal abnormalities: Down syndrome
(DS) DS was the most common chromosomal abnormality
in our study (74.7%) as well as in the other studies in Egypt
[69], followed by chromosomal deletions (4.23%) and other tri-
somies (2.30), (Table 4). In our Down syndrome patients there
was signiﬁcant increase in maternal age (above 35 years in
32.31%) compared to mean maternal age (25.8 years) [5]. In
52 R.M. Shawky et al.42.40% of cases the age of the mother was less than 35 years
which was considered high at that age. The frequency of
MTHFR 677 C/T and 1298 A/C polymorphism was signiﬁ-
cantly higher among Egyptian Down syndrome mothers,
32.1% and 57.1%, respectively compared to controls [70].
The same was also reported in another Egyptian study in
young aged Down syndrome mothers by Shawky et al. [71].
This indicates that Egyptian mothers are in need of folic acid
supplementations especially before and during the early
months of pregnancy.
Cytogenetic analysis revealed that the most common chro-
mosomal abnormality detected in Egyptian DS patients was
non-disjunction which constituted 95.4% and 93.98% in differ-
ent studies. This is followed by Robertsonian translocation
(2.7% and 3.5%) and then mosaic DS which comprised 0.7
and 1.84% of studied patients with DS [69,72]. Most cases of
translocation were t(21;21) which was present in 51.35% of
cases, followed by t(14;21), in 40.5%, t(13;21) in 5.4%, and
t(15;21) in 2.7% of cases [72]. Translocation was paternally
inherited in 33.3%of cases andmaternal transmission was twice
as common as paternal [69]. Non-classical karyotypes reported
in Egyptian patients with DS included: (46,X+21/46,XX),
(46,XX,der(21;21)(q10;q10),(47,XX+21/45,X), (47,XXY,der
(21;21)(q10;q10)+21),(48,XY,+21,+mar),(47,XY,+21,t (4;21)
(q31.1;q22),(46,XY,der(21;21)(q10;q10),+21/46,XY) (45,X/
47,XY,+21) and (48,XXY,+21) [72]; Zaki et al.) [73].
Eighty three percent of DS children had one or more con-
genital anomalies mainly affecting heart, kidney and vertebrae
[74]. Also DS patients were ﬁve times more liable to develop
acute leukemia than the general population [75]. Shawky
et al. [76] reported a remarkable variability in COL6A1 coding
region which can distinguish between individuals with DS with
or without congenital heart disease. They recommended the
study of other genes (COL6A2 and COL6A3) and their poly-
morphisms in these patients.
Different aspects of immune system were extensively stud-
ied in our DS children. A signiﬁcant decrease of total T-cells,
T helper cells and helper/suppressor ratio was found in these
patients, while T suppressor cell and natural killer cell percent-
ages were signiﬁcantly increased when compared to controls
[77]. The immune defect could be attributed to decrease in
plasma zinc level. Therefore zinc supplementation is recom-
mended in order to improve DS general health and
development.
Autoimmune diseases such as celiac disease were also com-
mon in our DS patients. The frequency of antigliadin and anti-
endomyseal antibodies seropositivity was 26.2% which was
higher among DS children with or without symptoms sugges-
tive of celiac disease. The seropositive children had signiﬁcantly
lower symptoms suggestive of celiac disease. The seropositive
children had signiﬁcantly lower weight and height, lower mean
hemoglobin level, lower serum albumin in comparison to sero-
negative counterparts. Therefore glutein free diet is recom-
mended for the treatment of celiac disease in these patients
[78].
The prevalence of thyroid autoantibodies and its associa-
tion with thyroid dysfunction in DS patients was studied by
Shawky et al. [79]. Sixty-ﬁve percent had positive antiperoxi-
dase antibodies and 32.5% had subclinical hypothyroidism.
Regular screening of thyroid dysfunction in DS and early
administration of L-thyroxin in antithyroid antibodies positive
patients is recommended.The pattern of regional cerebral blood ﬂow in our DS pa-
tients using brain single photon emission computed tomogra-
phy (SPECT) was also studied by Shawky et al. [80]. The
authors reported cerebral or cerebellar hypoperfusion in
82.35% using SPECT. Cerebellar hypoperfusion was encoun-
tered in cases with signiﬁcant hypotonia while frontal hypoper-
fusion was signiﬁcant in patients with behavioral disorders and
language delay. However, the role of vasodilators needs fur-
ther studies.
Early intervention program is the main worldwide support-
ive treatment for DS children. Shawky et al. [81] investigated
the effect of program of Portage on the progress of mental
development especially cognitive functions of DS children.
The earlier the start of early intervention program the better
the cognitive performance and the higher the IQ. They also
demonstrated the great impact of maternal education and fam-
ily size on the level of care the child receives.
Sex chromosome abnormalities: They constituted 18.72% of
all chromosomal abnormalities detected in our study (Table 4).
We conducted a study on 103 of our index cases, 69 females
and 34 males with suspected sex chromosome abnormalities.
The diagnosis was based on phenotype, hormonal proﬁle, pel-
vic-abdominal sonographic ﬁndings, and genotype (conven-
tional cytogenetics and molecular cytogenetics). The female
cases included 29 females with sex chromosome abnormalities
and 40 females with normal karyotypes. G- and C-banding
and subsequent FISH analysis of chromosomes revealed
numerical abnormalities in 52% of female index cases [10
non-mosaic and ﬁve mosaic cases], and structural sex chromo-
some abnormalities in 48% of female index cases [seven mosaic
and seven non-mosaic cases]. As regards male cases, sex chro-
mosome abnormalities were detected in 14 male index cases
and normal karyotype among 20 male index cases. Numerical
abnormalities were present in 86% of cases, and structural
abnormalities were found in 14% of cases. Klinefelter syn-
drome and its mosaic variants were present in 91.7% of
numerical cases, yet most of the cases were non-mosaic (nine
cases). One case with 47, XYY was found. Two types of struc-
tural abnormalities were present. One case with karyotype, 46,
inv(X)(p11.4q11.2), and in the second case sequential Q-band-
ing veriﬁed that the apparently normal Y chromosome was
missing its heterochromatic region which was translocated to
the terminal end of chromosome 7 sorting out the case as
46,XY,t(Y,7)(q;q).
Congenital malformations: Screening of newborns for con-
genital malformations Birth incidence of malformations in
Egyptian newborns ranges between 1.16% and 3.17% [82].
CNS malformations were the most common (9.33/1000) [83].
In a cross sectional study on a 1000 newborn infants deliv-
ered consecutively at the Department of Obstetrics and Gyne-
cology, Ain-Shams University, the incidence of congenital
anomalies (CA) was 2.7%. The highest frequency of congenital
anomalies involved the central nervous system (CNS) (33%),
followed in descending order by multiple congenital anomalies
(19%), skeletal system (15%), gastrointestinal tract (GIT)
(11%), urinary system (7%), and cardiovascular system anom-
alies (4%). Minor malformations accounted for 11% of con-
genital anomalies. Multiparity and diabetes mellitus were
associated with a higher incidence of congenital anomalies.
As regards infants of diabetic mothers 11% had major congen-
ital anomalies (two with VSD and one with spina biﬁda), 18%
had minor congenital anomalies (accessory ear tags, umbilical
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whorl of hair) [84].
Congenital malformations in infants and children: 13,543 in-
fants and children with congenital malformations attending
the Genetics Clinic were detected during the period of the
study (1995–2009), constituting 20/1000. The commonest sys-
tem involved was the nervous system (26.92%), followed by
chromosomal abnormalities (25%), genital organs (9.84), mus-
culo-skeletal (8.82), urinary system (8.67%), circulatory system
(6.55), eye, ear, face and neck anomalies (5.39%), other con-
genital anomalies (4.57%), digestive system (2.10%), cleft lip
and palate (1.5%) and respiratory anomalies (0.6%). Among
the maternal risk factors detected were multiparity, age of
the mother at conception, maternal illness, exposure to pollu-
tants and intake of drugs in ﬁrst 3 months of pregnancy. Con-
sanguineous marriages were detected among 45.8% of parents
[85].
Vertebral anomalies: The most prevalent types of develop-
mental vertebral anomalies in Egypt were congenital spinal
anomalies (42.5%) followed by osteochondrodystrophies
(35%). Meanwhile, miscellaneous disorders represented
22.5% of studied Egyptian children. Associated skull anoma-
lies were signiﬁcantly more encountered among patients
belonging to the group of osteochondrodystrophies (85.7%)
when compared with those having congenital spinal anomalies
(23.5%) while none of the patients with the miscellaneous dis-
orders had such anomalies. Craniofacial dysmorphism was evi-
dent in 42.9% of patients with osteochondrodystrophies.
Idiopathic scoliosis was associated with cleft palate in one case.
Congenital cardiac anomalies were reported in two patients
only; one of them had hemivertebrae and PDA while the other
had idiopathic scoliosis and VSD. Sacral agenesis was associ-
ated with micropenis and undescended testicles in one patient.
Mental retardation was recorded in two patients with congen-
ital hypothyroidism and one patient with spina biﬁda who
developed it as postmeningitic sequelae [86].
Craniofacial dysmorphism: A study carried out to evaluate
clinically as well as cytogenetically a non-selected group of
Egyptian children with craniofacial dysmorphism whether iso-
lated or part of a syndrome. 6.7% of patients had chromo-
somal abnormalities and 3.3% had microdeletion syndrome
(Rubenstein Taybi syndrome). Craniofacial dysmorphism
due to monogenic disorders was present in 34.3%, multifacto-
rial etiology in 20%, environmental factors in 6.7%, and un-
known etiology in 20% of cases. So the etiology of
craniofacial dysmorphism is very heterogeneous in Egypt.
Good observation and systematic examination can narrow
the differential diagnosis and the laboratory investigations
needed. High resolution karyotype is essential in all of these
cases [87].
Multiple congenital anomalies associated with mental retar-
dation: Another study was carried out to determine the preva-
lent forms of multiple congenital anomalies associated with
mental retardation among Egyptians trying to ﬁnd out if these
abnormalities were related to certain teratogens, genetic syn-
dromes or chromosomal aberrations. Twenty-six percent was
due to chromosomal abnormalities, 28% was syndromes due
to single gene affection, 13.3% was disorders caused by terat-
ogens and 33.4% was unclassiﬁed. The frequency of associated
anomalies was markedly increased in the mentally retarded pa-
tients compared to their controls, none of the controls had
three or more congenital anomalies compared to 89.2% inthe mentally retarded. The ﬁnding of three or more congenital
anomalies in a patient appears to indicate a signiﬁcant abnor-
mality in prenatal development. The discovery of multiple
associated anomalies in a mentally retarded child suggests that
the defect in brain function is also a congenital abnormality.
Minor anomalies may be useful diagnostic aids in the assess-
ment of patients with mental retardation [88].
4.4. Special senses
Hearing defect: The most common sensory defect in humans is
hearing impairment (HI). About 1/650 suffer from HI before
speech acquisition [89]. The prelingual deafness has a genetic
cause in 60% of cases [90].
In our Genetics Clinic hearing and verbal disorders consti-
tuted 1254 (4.37%) of our patients either isolated or part of a
syndrome.
Five hundred subjects of childhood deafness were studied
[91]. The patients were classiﬁed into three groups: the genetic
group comprised 218 (43.6%) children, 26.6% of children with
hearing loss alone, and 17% of children with hearing loss asso-
ciated with genetic syndromes. The acquired group comprised
250 (50%) children with hearing loss due to different acquired
causes: middle ear effusion in 23.6%, meningitis in 7.8%, peri-
natal anoxia in 6.4%, fever in 4%, viral infection in 2.2%, ker-
nicterus in 2%, garamycin injection in 1.6%, trauma in 1%,
maternal infection in 0.6%, tumors in 0.4%, burns in 0.2%
andmaternal drug therapy during pregnancy in 0.2%.The cryp-
togenic group (unknown cause) constituted 6.4% of patients.
Sequencing analysis of 159 Egyptians revealed C.35 del G
mutation in 10.8% of cases making it the most frequent muta-
tion in the GJB2 gene in Egypt. Five other mutations described
previously and three other novel mutations were also detected.
In contrast with most populations, the deletion (GJB6-
D13S1830) mutation upstream to the GJB2 gene was not pres-
ent in Egyptian population [92].
Ophthalmologic disorders prevalent among Egyptians: A vast
array of hereditary eye disorders has been identiﬁed. These in-
clude conditions limited to the eye as well as ocular manifesta-
tions of other heritable disorders and complex syndromes.
Congenital cataract and retinal degenerations rank high
among the genetic causes of blindness [93]. Genetic ophthalmic
diseases are prevalent in Egypt and they are assumed to cause
at least half of all cases of childhood blindness [94]. In our
study they constituted (1.58%). Optic nerve defects were the
commonest, (31.14%), followed by retinal defects (19.95%),
lens anomalies (cataract 18.81%), iris anomalies (3.69%), cor-
neal anomalies (7.72%), eyelid anomalies (2.46%), anophthal-
mia (7.25%), microphthalmia (3.46%), and eye anomalies as
part of a syndrome (5.52%).
Congenital cataract (CC): Mostafa et al. [95] reported that
sporadic cases 23/30, i.e. (76.66%) of CC in Egypt are more
common than familial cases 7/30, i.e. (23.33%). Temtamy
and Shalash [96] suggested autosomal recessive inheritance
for CC and microphthalmia.
Congenital glucoma (CG): El-Defrawy et al. [97] also re-
ported that sporadic cases of CG were more common 28/42
(66.66%) than familial cases 14/42 (33.33%). Three CYP1B1
mutations were identiﬁed in 45.4% of Egyptian and Saudi pa-
tients of which two were novel (homozygous E 173K and het-
erozygous N 498D) and the 3rd (G6IE) had been previously
reported. Also 10 single nucleotide polymorphisms were iden-
Table 5 Genetic varieties of hematologic disorders prevalent
among Egyptians.
Category Genetic Clinics
No. %
Inborn Errors Of Metabolism 1104 100.00
Inborn Errors of amino acids metabolism 645 58.42
PKU 278 25.18
Tyrosinemia 15 1.36
Alkaptonuria 12 1.09
Histidinemia 200 18.12
Homocystinuria 69 6.25
Hypermethionemia 4 0.36
Citrulinemia 3 0.27
Hydroxyprolinemia 4 0.36
Leucine, isoleucin, valine (MSUD) 23 2.08
Urea cycle defects 10 0.91
Organic aciduria 9 0.82
Valinemia 5 0.45
Hartnup disease 7 0.63
Cystinuria 1 0.09
Arginino-succinic aciduria 3 0.27
Lysinuria 1 0.09
Trimethyaminuria 1 0.09
Inborn Errors of CHO metabolism
(Glycogen storage diseases)
81 7.34
Lysosomal storage diseases 378 34.24
Mucopolysaccharidosis 307 27.81
Hurler 57 5.16
Hurler Schei 1 0.09
Schei 14 1.27
Hunter 93 8.42
Sanﬁlippo 17 1.54
Morquio 55 4.98
Maroteaux Lamy 70 6.34
Gaucher’s disease 48 4.35
Mucolipidosis 23 2.08
54 R.M. Shawky et al.tiﬁed in CYP1B1 and MYOC genes of which two were novel
[98].
Retinoblastoma:Molecular analysis of the RB 1 gene muta-
tions in peripheral blood lymphocytes of Egyptian families
were studied [99]. Speciﬁc molecular point mutations were
identiﬁed in seven exons of the RB 1 gene in 11 of the 15 exam-
ined Egyptian patients. These exons included exons 2, 11, 12,
13, 14, 17 and 26. In order of frequency, mutations of exon
14 were detected in (27%), mutations of exons 17 and 26 were
detected each in 18% and mutations of exons 2, 11, 12 and 13
were detected in 9% each. As regards genotype-phenotype cor-
relation, patients with mutations within exon 26 had an earlier
age of diagnosis and rapid progression of the tumor. Patients
harboring mutations within exon 17 had a later age of diagno-
sis and slow progression of the tumor while mutation within
exon 2 was detected in one child with multiple tumor foci. Spo-
radic occurrence of the tumor was identiﬁed in 60%, autoso-
mal recessive inheritance in 27% and autosomal dominant
inheritance in 13% of cases.
4.5. Inborn errors of metabolism (IEM)
IEMare individually rare, but collectively they constitute 4.24%
of patients attending ourGeneticsClinic, IEs of aminoacid (AA)
metabolism were the commonest followed by lysosomal storage
disorders (mainly mucopolysaccharidosis (Table 5). Hashem
[100] reported that in Egypt one in every 32 individuals carries
a gene for IEM.
In a study of the etiology of mental retardation in Egypt
[101], genetic causes represented 54.4%, of which the meta-
bolic causes represented 19.9%. These include IEs of AA
(11.5%) and MPS (8.4%). In another study in our clinic,
aminoacidopathies were represented in 1.5% of total patients
attending the Genetics Clinic among them phenylketonuria
(PKU) was found to be the commonest, 1.11%, while the
remaining diagnosed cases represented 0.07% for each of
alkaptonuria, citrulenemia, and trimethyl-aminuria [102].
Screening programs in Egypt: A general screening program
including 2000 infants was done in 2001 from plasma samples
[103]. Transient neonatal tyrosinemia was detected in 0.05%
and generalized aminoacidemia in 0.05%. As regards the selec-
tive screening program, among the 450 cases of mental retar-
dation (MR) examined, 280 cases were suspected of having
inborn errors of amino acid metabolism by speciﬁc criteria ta-
ken as markers, e.g. convulsions and/or progressive neuromen-
tal deterioration, speech defect and/or deafness, mental
retardation (MR) with no acquired or chromosomal etiology
and organic brain damage of obscure etiology. Among the
51 cases (11.32%) with conﬁrmed positive inborn errors of
amino acid metabolism, 40 cases (78%) had (PKU), four cases
(7.84%) had generalized aminoaciduria, two cases (3.92%)
had non-ketotic hyperglycinemia, two cases (3.92%) had
hyperprolinemia, two cases (3.92%) had histidinemia and
one case (1.96%) had homocystinuria. PKU cases can be clas-
siﬁed into, classic type (90%), atypical type (7.5%) and malig-
nant type (2.5%). The main clinical ﬁndings included
hypopigmentation (100%), MR (100%), physical retardation
(90%), microcephaly (37.5%), hyperactivity (90%), seizures
(25%), and abnormal EEG (42.5%). The associated abnormal-
ities include three cases (7.5%) with albinism, and three cases
(7.5%) with eye abnormalities; namely enophthalmos, glau-
coma, and optic atrophy.In another extended metabolic screen done in 2004 on 232
cases (44 neonates and 187 children) with symptoms suggestive
of IEM [104]. Abnormal results were detected in 22.73% of
neonates. Organic acidemias were detected in 13.63%, amino-
acidopathies in 4.55%, fatty acid oxidation defects in 4.55%.
In children abnormal results were also detected in 8.56% of
children, including aminoacidopathies in 5.88%, organic
acidemias in 1.07%, cystic ﬁbrosis, congenital adrenal hyper-
plasia and congenital hypothyroidism in 1.61%, PKU was de-
tected in 6.48% of children with MR, and MSUD in 10% of
children with convulsions.
Phenylketonuria (PKU): Phenylketonuria is the most com-
mon inborn error of metabolism in Egypt – 1:7500 [100,105]. It
was found that classic PKU is the most prevalent type of
hyperphenylalaninemia (92.08%), followed by atypical hyper-
phenylalaninemia (6.67%) and benign hyperphenylalaninemia
(1.25%) [106].
Screening carriers and prenatal diagnosis: A study was done
on our patients to screen the PAH locus for potentially useful
short tandem repeats (STRs) as markers for carrier detection
in PKU families and to determine the level of PAH heterozy-
gosity within the Egyptian population. The system contains at
least eight independent alleles in Egyptian population, trans-
mitted in Mendelian fashion. The most frequent allelic frag-
ment size was 246 bp (35.7%) which together with a
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mosomes. Variations in the number of STR in the families
studied gave rise to polymorphisms that proved to be suitable
markers for PKU carrier detection and prenatal diagnosis
[107].
Mutation analysis of PKU: A study for mutations and poly-
morphism in PAH gene among our patients was done. Four
mutations were detected, IVS 10 nt-11 gla and Y 198fs, IVS
2 nt5 glc, E7 G247V. Interestingly the last mutation has only
been described in Chinese, thus allowing future comparison
with Chinese alleles. Also ﬁve polymorphism was identiﬁed,
IVS2 nt 19t/c, E6 Q232Q, E11 L385L, E7V245V, IVS 12
nt16 t/g (not previously reported among Egyptian, although
it was reported in Sicily). This suggests gene ﬂow between Sic-
ily and Arab countries [108]. In another study on our patients
mutation analysis on unrelated 51 families was done. A novel
missense CpG site R243P mutation was identiﬁed. Moreover,
three new known mutations L48S, delEX3 and Y277D un-
reeled in the Egyptian population. The ten detected mutations
covered 58%, representing 47 positive chromosomes. The most
common mutation was represented by IVS10nt546 (10.8%),
while the total missense mutations in our sample group ac-
counted for the majority of mutations 40%. The high hetero-
zygosity of the mutant PAH locus in Egypt suggests that
multiple founder events would explain the presence of hyper-
phenylalaninemia in Egypt. Further studies will however be
necessary to fully exploit the potential of PAH gene analysis
to reconstruct the genetic history of PKU in Egypt in context
with migrations among European and Mediterranean popula-
tions [109].
Glycogen storage: Endo et al. [110] detected three different
individual AGL mutations in Egyptian glycogen storage dis-
ease patients, two were novel deletions (750–753del AGAC)
and 1 bp deletion 2673del T. One, the non-sense mutation
(W1327X) was previously reported. Haplotype analysis of mu-
tant AGL alleles showed that each mutation was located on a
different haplotype. Thus allelic heterogeneity of the AGL
mutation in Egypt was conﬁrmed.
Lysosomal storage: Hashem [100] reported 38 cases of neu-
rolipidosis, Leigh disease in 13 cases, GM1 Gangliosidosis in
11 cases, GM2 gangliosidosis in six cases, mucolipidosis in
six cases and a single case of Refsum disease. Metachromatic
leucodystrophy was diagnosed in seven cases. In a study of
30 patients with developmental delay or loss of previously ac-
quired milestones of development one case with Gaucher dis-
ease, one case with arylsulphatase A pseudodeﬁciency, one
case with Pelizaeus–Merzbacher disease and 2 cases with infan-
tile metachromatie leucodystrophy were diagnosed [29]. Degh-
ady et al. [111] demonstrated that Egyptian patients with type
1 Gaucher disease, whether newly diagnosed or receiving en-
zyme replacement therapy, experience coagulation factor
abnormalities regardless the clinical expression of bleeding
diathesis. This should be taken into consideration before these
patients are subjected to surgery for, e.g., splenectomy, which
is common in these patients.
Mucopolysaccharidosis: Hashem [100] reported 77 index
cases with mucopolysaccharidosis and 28 of their relatives.
23 cases had Hurler syndrome, 16 cases had Morquio disease,
12 cases had Hunter disease, 10 cases had Hurler/Schaie, 9
cases had Sanphillipo disease, four cases with Maroteau–Lamy
and three cases had Schie. However, in another study MPS VI
was the commonest type detected (33.3%), followed by MPSIII and IV (22.2% for each), MPS I (11.1%), MPS II
(5.6%), MPS VII (5.06) [112]. Cardiac abnormalities were de-
tected in 61.1% of patients. The mitral valve was the most
commonly affected valve (40%) in the form of thickening of
the valve or mitral regurge, followed by interventricular septal
hypertrophy (15%), ventricular wall hypertrophy (15%) and
thickening of coronaries (10%). Ocular abnormalities were de-
tected in 30% of our patients mainly as corneal opacities
(16.7%), optic atrophy (5.6%), papilloedema 11.1%, pigmen-
tary retinopathy (5%) and increased intra-ocular pressure
(5.6%) [112].
Gaucher disease (GD):Most of Egyptian children with GD
have type III disease and L444P/L444P genotype, and so a
minimum dose of cerezyme 60 mg/kg/2 weeks should be main-
tained until adulthood. Higher doses started at an early age
may delay the progression of neurological symptoms. Pulmon-
ary involvement is not rare in Egyptian patients and may re-
spond to dose increase or dose fractionation. Cardiovascular
and renal symptoms should be further studied in our popula-
tion [113]. Shawky and Elsayed [114] reported the unusual
ﬁnding of concentric ventricular hypertrophy and multiple
stones in the right kidney in a patient with Gaucher disease.4.6. Neuromuscular disorders
The genetic varieties of the neuromuscular disorders depicted
in the present survey were drained from different areas of
Egypt. The diagnosis was mainly ascertained on clinicogenea-
logic basis. They constitute 2.86% in Genetics Clinics and
0.12% in the Pediatric Hospital with Duchenne/Becker muscu-
lar dystrophy being (D/BMD) the commonest error (Tables 1
and 6).
In 1998, Hashem and Elsayed [115] conducted a study in
our clinic to determine the phenotypic expression and gene fre-
quency of the different groups of primary myopathies. The
genealogic pedigree analysis of the studied index families re-
vealed that Duchenne muscular dystrophy (DMD) also had
the highest incidence followed by the congenital myopathies
and limb girdle muscular dystrophy (LGMD). As regards
the phenotypic expression of muscle dysfunction: weakness,
hypotonia and hyporeﬂexia was detected in 100% of cases.
No sensory or cerebellar affection has been detected. Pseudo-
hypertrophy was noted in 40.41% of cases, of whom 36%
had DMD 3% had LGMD and 1% myotonia congenita.
Atrophy occurred in about 72.83% of cases and contractures
occurred in 10%. The gene frequency of the different groups
of primary myopathies was 0.000136 for X-linked, 0.0059 for
autosomal recessive and 0.0000097 for autosomal dominant.
The carrier % of the different groups of primary myopathies
was 0.0272 for X-linked, 1,180 for autosomal recessive. The to-
tal anticipated patient load of the different groups of primary
myopathies was 4132 for X-linked, 351,872 for autosomal
recessive and 573 for autosomal dominant. The anticipated
carrier load of the different groups of primary myopathies
was 7883 for X-linked and 699,565 for autosomal recessive.
Duchenne muscular dystrophy: As Partial gene deletion is
the major type of mutation leading to Duchenne muscular dys-
trophy (DMD), the commonest type of primary myopathy in
this study, and its mild allelic form, Becker muscular dystro-
phy (BMD). A study was conducted on the dystrophin patients
using multiple primers and detected 51.3% of probands with
56 R.M. Shawky et al.deletion mutations [116]. In order to offer carrier detection, ge-
netic counseling and prenatal diagnosis to families with D/
BMD in our country, pedigree analysis, estimation of the
CPK level and the segregation analysis of highly polymorphic
short tandem repeats were evaluated by Elhawary et al. [117].
Analysis of the D/BMD index families allowed the categoriza-
tion of the females at risk into three categories: 25.7% deﬁnite
carriers, 5.71% probable carriers and 68.57% possible carriers.
Spinal muscular atrophy (SMA): It constituted 21.87% and
the second most common neuromuscular disorder in our study
is characterized by progressive hypotonia and muscular weak-
ness because of progressive degeneration of alpha motor neu-
ron from anterior horn cells in the spinal cord. It is inherited
by an autosomal recessive pattern. The precise frequency of
SMA in Egypt has not been determined previously. We tried
to estimate the frequency, clinical and molecular characteris-
tics of SMA in Egypt. The study included all patients with
SMA attended the Pediatric Hospital, Ain-Shams University
during the period (year 1966–2009). The study included 117
patients with SMA out of 660,280 patients attending the Pedi-
atric Hospital. Frequency of SMA was 17.7/100,000, which is
considered high. Type I was the commonest type (60.6%), fol-
lowed by type II (26.79%), and type III (8.8%). Consanguinity
was reported in 45.5% and family history in 47.8% of patients.
The most common complain were recurrent chest infection,
hypotonia and weakness in all type I patients (67.5%) second-
ary inability to walk in all type II patients (27.3%), and weak-
ness and difﬁculty in walking in all type III patients (5.2%). All
type I patients presented with profound weakness and hypoto-
nia, but wasting was not marked because of early death. Deep
reﬂexes were absent, sensations were intact and mentality was
normal. Tongue fasciculations were prominent and hand trem-
ors were present in the second and third groups of patients.
Molecular study was done to identify mutations involving
the SMA gene in Egyptian patients with proximal SMA, so
that prenatal diagnosis in informed families can be performed.
DNA molecular studies of the SMA gene on the long arm of
chromosome 5 (5q11.2q13.3) revealed homozygous deletion
of exon 7 in 55% of cases, 36.3% of whom also had homozy-
gous deletion of exon 8. The adult patients were heterozygous
for an abnormal size exon 8. The remaining patients had eitherTable 6 Genetic varieties of neuromuscular disorders pre-
valent among Egyptians.
Category Genetic Clinics
No. %
Neuromuscular disorders 823 100.00
Primary myopathies 627 76.18
Muscular dystrophies 523 63.54
X-linked muscular dystrophy 384 46.65
Autosomal muscular dystrophies 139 16.89
Myotonic disorders 20 2.43
Congenital myopathies 84 10.21
Neuromuscular junction disorders
(myasthenia gravis)
8 0.97
Peripheral neuropathies
(Charcot–Marie tooth disease)
8 0.97
Anterior horn cell diseases
(hereditary spinal muscle atrophy)
180 21.87compound heterozygote deletion of exons 7 and 8 or was nor-
mal for both. There may therefore be 5q unlinked SMA or
SMA due to other mutations. Detection of deletions of SMA
exons 7 and 8 is a powerful diagnostic test in patients with
SMA, but other mutations among Egyptians must also be
sought of [118,119].
4.7. Rare syndromes reported in our clinics
Melnick needles syndrome: We reported the ﬁrst Egyptian pa-
tients with this syndrome with amenorrhea, short stature and
characteristic facial dysmorphism [120].
Martsolf syndrome: An Egyptian girl was also reported with
this syndrome [121].
Femoral hypoplasia unusual facies syndrome: It was reported
in a four-year old male who had complete absence of both fem-
ora, and bilateral undescended testes [122].
Hypomelanosis of Ito (HI): HI and rapidly progressing
neuroblastoma was described. To our knowledge, neuroblas-
toma was reported only once in the literature [123].
MURCS association: A two year old girl with typical fea-
tures of this association was described with right deviation of
anorectal canal, subglottic stenosis and unilateral oblique
inguinal hernia [124].
Frontofacionasal dysplasia: A patient with this dysplasia
was described who had severe craniofacial anomalies and
was associated with facial heamangioma [125].
Peter’s plus syndrome: A case of Peter’s plus syndrome with
some unusual features, such as progressive osseous hypoplasia
was described [126].
Other syndromes reported in our locality include: Corpus
callosum defect with dilated lateral ventricles and one occipital
cyst in an Egyptian child with Diamond–Blackfan syndrome
[127], acrocallosal syndrome [128], triple A syndrome present-
ing with myopathy [129], abnormal presentation of Peter’s
anomaly in a family with microcornea, and cataract [130], Ellis
Van Creveled syndrome with facial dysmorphic features [131],
Goldenhar syndrome with skin tags on the chest wall [132],
multiple pterygium syndrome with marked pterigia of the ﬁn-
gers and MRI changes in the spine [133], juvenile hyaline ﬁbro-
matosis (JHF): in an Egyptian 3 years old male child was also
reported [134], progressive osseous heteroplasia was also de-
scribed [135], C syndrome [136], holoprosencephaly, a report
of two cases with different presentations [137] and the ﬁrst re-
port of an Egyptian patient with ﬁbrodysplasia ossiﬁcans pro-
gressive (FOP) was also presented [138].
4.8. Genodermatoses prevalent among Egyptians
It is not an overestimate to state that at least 90% of chronic
dermatoses are genetically mediated either totally or conse-
quent to genomic interaction with speciﬁc environmental
agents which are only noxious to genetically predisposed
individuals.
The present survey depicts the genetic varieties of primary
chronic dermatoses which were encountered amidst 553 index
Egyptian families who consulted Ain-Shams University mainly
for genetic counseling. They constitute 1.92 of patients attend-
ing the Genetics Clinics and 0.083 in the Pediatric Hospital.
The genetic varieties of dermatoses in this study were drained
from different areas in Egypt (Table 7).
Table 7 Genetic varieties of genodermatoses prevalent among
Egyptians.
Category Genetic Clinics
No. %
Genodermatosis 553 100.00
Ichthyosis 204 36.88
Lamellar 71 12.83
X-linked 23 4.15
Vulgaris 27 4.88
Congenital ichthyosiform erythroderma 56 10.12
Sjogren–Larsson syndrome 27 4.88
Albinism 113 20.43
Partial 52 9.40
Complete 49 8.86
Ocular albinism 2 0.36
Hemansky Pudlac Syndrome 2 0.36
Cross syndrome 2 0.36
Chediac Higashi Syndrome 6 1.08
Epidermolysis bullosa 94 16.99
Xeroderma pigmentosa 88 15.91
Isolated 67 12.11
De-Scantis Cacchione Syndrome 21 3.79
Ectodermal dysplasia 54 9.76
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albinism (20.43%), epidermolysis bullosa (16.99%), xero-
derma pigmentosa (15.91%) and ectodermal dysplasia
(9.76%) (Table 7). This is in accordance with previous studies
in the same locality [100,139]. The parental birth origin indi-
cates that Lower Egypt had the highest parental birth origin
(42.58%), followed by Cairo (26.89%), and then Upper Egypt
(27.73%). It is important to know the parental birth origin, be-
cause there may be certain population groups in whom a mu-
tant allele is carried more frequently because of the founder
effect or heterozygote advantages. Such epidemiological infor-
mation allows appropriate screening and counselling. Consan-
guinity was present in 75.63% of our patients, and constitutes
40% and 51.54% of patients had positive family history.
Age incidence was high in the neonatal period as in ichthy-
osis, early in the ﬁrst year of life (1 month to <1 year) in ecto-
dermal dysplasia while in albinism it was higher in early
childhood (2 years to <6 years). As regards sex distribution,
male to female ratio was 1.1:1. The same was also reported
previously [139,140]. Strikingly there was high incidence of dia-
betes mellitus in 17.68%, mental retardation in 13.11% and
seizures in 10.37% followed by hypertension in relatives of pa-
tients in this study.
Ichthyosis: Lamellar ichthyosis (LI) constituted the com-
monest type in our study 12.83%, followed by congenital ich-
thyosiform erythroderma 10.12% (Table 7). There was a high
incidence in newborns (62.5%). The distribution of scales var-
ies according to the type of ichthyosis. It was distributed all
over the body in 60.58% of cases, over the extremities in
91.35% and over the trunk in 84.62% of cases. Erythema
was present in 18.27%. Ectropion is present in 10.58%, spastic
dysplasis in 11.54% and mental retardation in 22.12% of
cases. Associated genome errors reported in our patients in-
cluded seizures in 4.81%, Down syndrome in 0.96%, Duch-
enne muscular dystrophy in 0.96%, undescended testes in
2.88%, speech defect in 16.35% and growth retardation in
13.46%.
Analysis in both inbred and outbred families in United
States and in Egypt showed that LI was linked to several
markers within a 9.3-cM region on 14q11. Affected individuals
in inbred families were found to have striking homozygosity
for markers in this region. Linkage-based genetic counseling
and prenatal diagnosis are now available for informative at-
risk families. The transglutaminase-1 gene maps to the same
region and encodes one of the enzymes responsible for cross-
linking epidermal proteins during the formation of the stratum
corneum [141]. Russell et al. [141,142] showed that TGM1 and
LI were linked with no recombinants; maximum lod = 9.11.
We extended our previous dataset to update the detection
of R142H mutation in 4 CIE and one LI phenotype Egyptian
families. This mutation was detected in 28.8%; whereas we still
had no R141H among our Egyptian population. There was no
correlation between phenotype and genotype in our study.
Surprisingly, the mutant alleles detected in intron-5 acceptor
splice-site were associated with the other extreme of CIE phe-
notypes rather than the severe LI form. We clearly demon-
strated that the ARCI Egyptian families in Upper Egypt was
ethnically pure and had a tendency not to be a hybrid with
other populations in Lower Egypt, Delta zone and Cairo city
[143]. Sixteen percent of the index ichthyotic patients of the
autosomal recessive category in the present survey manifested
a wide spectrum of neurologic manifestations. All patients ofthis category were designated as having ‘‘Sjogren–Larsson syn-
drome’’ (SLS).
In seven pedigrees of diverse ethnic origins (three families
from Egypt, three families from the United States and one
Arab family from Israel), Rogers et al. [144] conﬁrmed the
linkage of SLS to the pericentric region of chromosome 17.
Albinism: The occurrence rate of Albinism in our clinic was
20.43% of all genodermatoses patients. The commonest type
was complete OCA followed by partial albinism, syndromic
albinism (Table 7). Associated genomic errors detected in
our albino patients included microphthalmia in 27.27%, men-
tal retardation in 19.32%, seizures in 15.91%, deafmutism in
4.55% and Down syndrome in 3.04% [145].
Xeroderma pigmentosa: There was high incidence of XP in
the childhood period (53.18%). As regards sensitivity to sun,
it was present in 100% of cases, photophobia in 71%, mental
retardation in 73%, microcephaly in 59%, hyporeﬂexia in
36%, seizures in 34%, and corneal opacities in 26.79% of cases
studied. Genomic errors detected in our patients included
dwarﬁsm in 16.07% and hypogonadism in 8.93%.
Epidermolysis bullosa: Epidermolysis bullosa constituted
16.99% of our patients with genodermatoses. There was also
a high incidence in newborns (47.50%). As regards the pheno-
type blisters were present in 100% of cases, non-scaring lesions
in 9% granulomas in 12.05%, secondary infection in 77.50%,
dystrophic nails in 32.50% loss of teeth in 5%, growth retarda-
tion in 5% and hand and foot deformity in 7.5% of our
patients.
Ectodermal dysplasia (ED): A high incidence of ED was
detected in early infancy. As regards the phenotypic expression
of ED, decreased sweating was present in 92%, dry skin in
69%, hypodontia in 65%, sparse eyebrows and eye lashes in
73%, sparse body hair in 65%, hypoplastic nails in 30% and
hypotrichosis of the scalp in 88% of cases. Genomic errors de-
tected in these patients included atrophic rhinitis in 3.85% of
cases and hypopigmented periorbital skin in 50% of cases.
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For a long time we believed that cystic ﬁbrosis is not present in
Egypt. Abdel Salam et al. [146] diagnosed cystic ﬁbrosis in
4.6% of studied cases with clinical picture suggestive of dis-
ease. Median age of diagnosis of cystic ﬁbrosis in Egypt is
4 years which was higher than the age reported in other studies
in Arab and Western countries. This is due to the delay in diag-
nosis. Newborn screening was done using a three-tier neonatal
screening method on 924 newborns taking a heel prick on
Guthrie cards during ﬁrst three days of life. The test included:
quantitative immunoreactive trypsinogen, double sweat chlo-
ride test and DNA analysis for the detection of DF508 for po-
sitive cases. Cystic ﬁbrosis was conﬁrmed in 3 infants (0.32%).
DF508 mutation was conﬁrmed in two infants in heterozygous
state (33%) [147]. Also this mutation comprised 25% of muta-
tions in a high risk group of children with chronic lung disease
[148]. This indicates the relatively low frequency of DF508
homozygotes among our normal populations. Accordingly
we cannot depend on this mutation alone in our country which
comprises over 80% of mutations in other countries [149] and
further studies must be done to know the mutational pattern of
the disease among our population to plan a strategy for
screening.
4.10. Endocrine disorders and abnormalities of sexual
differentiation
They constitute 3.87% of patients attending the Genetics Clin-
ics and 0.17% in the Pediatric Hospital.
Congenital hypothyroidism: Hypothyroidism was found in
1/5495 newborns in our locality [100]. She found that 75%
of all hypothyroidism was due to a primary defect in the thy-
roid gland or in the enzymatic synthesis of the thyroid hor-
mone, while 25% was due to pituitary or hypothalamic
disorders.
The Egyptian Ministry of Health and Population started to
implement the national screening program for congenital
hypothyroidism in the year 2000, in ﬁve governorates and by
the end of 2003 all 27 governorates were covered.
The total No. of screened neonates is about 4.8 millions by
the end of December 2005 coverage ranged from >95% in
some rural areas to 75% in urban areas.
The overall incidence of hypothyroid patients was 1/2020 in
the year 2005 [150].
The prevalence of goiter by clinical indicator was 11.8%.
The prevalence of iodine deﬁciency disorders (IDD) by urinary
iodine estimation was 31%, 90% of the cases were considered
to have mild deﬁciency. Higher mean TSH levels were found
among goitrous subjects. The prevalence of hypothyroidism
among IDD children was 6.1% with 3.9% being compensated.
A negative correlation (p< 0.01) was detected between the
severity of iodine deﬁciency and the degree of salt iodization.
On the other hand iodine deﬁciency was detected in 9.7% of
children who consumed iodized salt, and normal urinary io-
dine levels were detected in 50.6% of children inspite of the
use of non-iodized salt. This means that iodine deﬁciency con-
tinues to be a major health problem in Egypt [151].
Abnormal sexual differentiation: Prevalence and phenotypic
expression of various genitogonadal differentiation errors were
studied in 322 index cases registered in our Genetics Clinic. Itwas found that gonadal dysgenesis with abnormal chromo-
somal complement was the most common disorder, 34.67%
(Klinefelter syndrome 14.24% and Turner syndrome
20.43%), followed by gonadal dysgeneses with normal chro-
mosomal complement, 19.50% (XXY type 12.38% and XY
type 7.12%). True hermaphroditism constituted 10.53% (com-
plete androgen insensitively syndrome, 8.05%, and partial
androgen insensitivity syndrome 2.48%). On the other hand
female pseudohermaphroditism constituted 4.02% of studied
subjects (congenital adrenal hyperplasia, 3.72% and androgen
secreting tumors 0.31%). Mullerian dysgenesis constituted
29.10% of our patients. In this study adulthood was the most
common presenting age group, 63.78%, Lower Egypt was the
most common birth origin, 49.23% [152]. On the other hand
Mazen et al. [153] reported that 46XY disorders of sexual dif-
ferentiation (DSD) were more common in Egypt (65.9%) than
46,XX DSD. Also familial cases of male pseudohermaphrodit-
ism were reported by Hashem [154].
Shawky et al. [155] tested the presence or absence of SRY
gene in patients with intersex using FISH technique and
(LSI) SRY/CEP X dual color probes.
G banding revealed normal male karyotype in 48% of pa-
tients, normal female karyotype in 43% of patients and abnor-
mal karyotype in (45,X,+mar) in 9% of patients. Gad [156]
studied CYP21 mutations in two patients with CAH, both
were homozygous for the II72N mutation. Their mothers were
both heterozygous for the mutation.
5. Conclusion
Over the years, Egypt has made substantial progress in control
of communicable diseases. This leads to emergence of non-
communicable diseases including genetic disorders. Our study
showed a high prevalence of genetic diseases among Egyptians
which is nearly the same in the other studies in Egypt and are
rapidly becoming a major public health concern.
Establishment of national or hospital based registers for ge-
netic disorders are very important to know the magnitude of
the problem so that the national program for prevention of ge-
netic disorders can be implemented. This program should be
carefully selected to match the unique, demographic, cultural
and religious characteristics of the Egyptian populations and
should take into considerations the priorities of the more com-
mon disorders. We have to expand genetic education of health
professionals, ofﬁcials in charge of patients, their families and
general public. Carrier detection, genetic counseling, premari-
tal diagnosis, neonatal screening, preconception, prenatal
diagnosis and selective screening programs are of great impor-
tance in the prevention of genetic disorders. Promotion of sci-
entiﬁc research efforts in the ﬁeld of human genetics to
implement country speciﬁc data-base mutations and develop-
ment of Arab human variome project are also important.
Expand genetic education of health professionals, ofﬁcials
in charge of patients, their families and general public.
Carrier detection, genetic counseling, premarital diagnosis,
neonatal screening, preconception, prenatal diagnosis and
selective screening programs are of great importance in the
prevention of genetic disorders.
Promotion of scientiﬁc research efforts in the ﬁeld of hu-
man genetics to implement country speciﬁc data-base muta-
tions and development of Arab human variome project.
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